T

Texas Health Physicians Group | Cardiology & Interventional Vascular Associates

Research site

(Unclaimed)

Location

7150 Greenville Avenue, Dallas, Texas, United States of America

Site insights

Top conditions

Top treatments

LY3314814

LY3298176

Lorcaserin HCl

BELVIQ

Celecoxib

Tiotropium

sodium

Naproxen

Ibuprofen

Lanabecestat

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 11 total trials

A Study of Ponsegromab in People With Heart Failure (GARDEN TIMI 74)

The primary purpose of this clinical trial is to compare the effects of study medicine (Ponsegromab/PF-06946860) with a placebo (an injection that lo...

Enrolling

Heart Failure

Drug: Optional Cohort C: Ponsegromab low dose

Other: Optional Cohort C: Matched placebo

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting

Type 2 Diabetes Mellitus

Drug: Tirzepatide

Drug: Dulaglutide

Locations recently updated

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting

Atherosclerotic Cardiovascular Disease

Drug: Placebo

Drug: Inclisiran sodium 300 mg